Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
The Journal of Experimental Medicine
|
May 3, 2000
Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA
M Kruse, O Rosorius, F Krätzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 8, 2001
Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta
M Kruse, E Meinl, G Henning, et al.
Journal of Virology
|
July 11, 2000
Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity
M Kruse, O Rosorius, F Krätzer, et al.
Leukemia Research
|
February 7, 2009
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia
B D Hock, L J Fernyhough, S M Gough, et al.
The Journal of Experimental Medicine
|
December 19, 2001
The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells
M Lechmann, D J Krooshoop, D Dudziak, et al.
Human Genetics
|
May 1, 1993
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
J K Tarlow, A I Blakemore, A Lennard, et al.
Kidney International
|
March 1, 1996
Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis
F W Tam, A M Karkar, J Smith, et al.
FEBS Letters
|
September 21, 1992
Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues
A Steinkasserer, R Solari, H R Mott, et al.
Tissue Antigens
|
February 3, 2006
Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients
B D Hock, J L O'Donnell, K Taylor, et al.
Journal of Molecular Biology
|
July 5, 1993
Solution structure of a pair of complement modules by nuclear magnetic resonance
P N Barlow, A Steinkasserer, D G Norman, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
The Journal of Experimental Medicine
|
May 3, 2000
Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA
M Kruse, O Rosorius, F Krätzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 8, 2001
Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta
M Kruse, E Meinl, G Henning, et al.
Journal of Virology
|
July 11, 2000
Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity
M Kruse, O Rosorius, F Krätzer, et al.
Leukemia Research
|
February 7, 2009
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia
B D Hock, L J Fernyhough, S M Gough, et al.
The Journal of Experimental Medicine
|
December 19, 2001
The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells
M Lechmann, D J Krooshoop, D Dudziak, et al.
Human Genetics
|
May 1, 1993
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
J K Tarlow, A I Blakemore, A Lennard, et al.
Kidney International
|
March 1, 1996
Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis
F W Tam, A M Karkar, J Smith, et al.
FEBS Letters
|
September 21, 1992
Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues
A Steinkasserer, R Solari, H R Mott, et al.
Tissue Antigens
|
February 3, 2006
Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients
B D Hock, J L O'Donnell, K Taylor, et al.
Journal of Molecular Biology
|
July 5, 1993
Solution structure of a pair of complement modules by nuclear magnetic resonance
P N Barlow, A Steinkasserer, D G Norman, et al.
Page
of 7